Please assess the completion status of the following clinical trial:

Trial Title: Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy non-pregnant adults aged 18-40 years and children aged 1-17 years~Exclusion Criteria:~* Diarrhea during the past week~* Antibiotic and anti-diarrheal medicine use during the past week~* One or more episodes of diarrhea or abdominal pain lasting for 2 weeks during the past 6 months~* Abdominal pain, nausea, vomiting, loss of appetite or generalized ill feeling for the past 24 hours~* Pregnancy

- Gender: ALL
- Minimum Age: 12 Months
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Killed Whole Cell Oral Cholera Vaccine
- 2 (Type: PLACEBO_COMPARATOR): Heat-killed E. coli

Based on this trial design, predict the completion outcome and termination type (if applicable).